416.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ELV Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$396.90
Aprire:
$407.38
Volume 24 ore:
1.90M
Relative Volume:
1.40
Capitalizzazione di mercato:
$90.33B
Reddito:
$201.11B
Utile/perdita netta:
$4.95B
Rapporto P/E:
18.51
EPS:
22.4991
Flusso di cassa netto:
$6.29B
1 W Prestazione:
+0.42%
1M Prestazione:
+4.74%
6M Prestazione:
+47.35%
1 anno Prestazione:
+35.79%
Elevance Health Inc Stock (ELV) Company Profile
Nome
Elevance Health Inc
Settore
Industria
Telefono
(800) 331-1476
Indirizzo
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health Inc
|
416.54 | 86.08B | 201.11B | 4.95B | 6.29B | 22.50 |
|
UNH
Unitedhealth Group Inc
|
388.28 | 352.81B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
95.29 | 121.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
CI
Cigna Group
|
280.91 | 73.50B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
400.73 | 48.03B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-08 | Iniziato | Evercore ISI | In-line |
| 2026-02-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Iniziato | Goldman | Neutral |
| 2025-07-21 | Downgrade | Argus | Buy → Hold |
| 2025-07-18 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Downgrade | Argus | Buy → Hold |
| 2024-07-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-06-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-07-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
Mostra tutto
Elevance Health Inc Borsa (ELV) Ultime notizie
Elevance Health Inc (ELV) Shares Surge 5.0% -- What GF Score of 90 Tells Investors - GuruFocus
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Buy Elevance Health Stock For The Margin It Lost? - Trefis
Elevance Health reaffirms FY26 EPS guidance, shares rise 5% - scanx.trade
Elevance Health stock gains after 2026 earnings guidance is reaffirmed - ad-hoc-news.de
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation - Benzinga
Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement - TradingKey
Elevance Health reaffirms 2026 earnings and benefit expense guidance - Investing.com
Elevance Health Gains as Investors Revisit Medicare Advantage Tailwinds - Quiver Quantitative
Elevance Health (ELV) Reaffirms 2026 Earnings Guidance of at Lea - GuruFocus
Elevance holds loss ratio guidance above 90% as fall renewals near - Insurance Business
Elevance Health at Wells Fargo conference: growth plan stays on track - Investing.com UK
Elevance Health Inc's Dividend Analysis - GuruFocus
Form 8K Elevance Health Inc For: 10 September By Investing.com - Investing.com Canada
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com Canada
Elevance Health (NYSE: ELV) sticks with its 2026 profit target - Stock Titan
Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Elevance Health stock falls amid sector worries over rising medical costs - ad-hoc-news.de
Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $488 - Moomoo
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Elevance Health EVP and Chief Legal Officer Wessling Erin M Forfeits 349 Shares, Retains 7,230 Shares - Kalkine Media
Elevance Health stock falls on softer dividend yield and valuation concerns - AD HOC NEWS
Elevance Health stock holds after strong quarterly beat - AD HOC NEWS
Elevance Health, Inc. (ELV) Stock Analysis: Evaluating A 10% Upside Potential - DirectorsTalk Interviews
Elevance Health stock holds steady as Medicare Advantage shift and dividend set the tone - AD HOC NEWS
Health insurer Anthem targeted in lawsuit over air ambulance claims - The Republic News
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
Elevance Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
Elevance Health (NYSE: ELV) withholds 349 shares to cover EVP tax liability - Stock Titan
EVP at Elevance Health (NYSE: ELV) now holds 6,530 shares after tax withholding - Stock Titan
Elevance Health Settles Ex-Worker's Late Pay Class Claims - Law360
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy? - TradingView
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Elevance Health (NYSE:ELV) Valuation Gap Persists After Rally - Kalkine Media
Is UnitedHealth Finally Turning the Corner After a Tough 2025? - TradingView
How Is Elevance Health’s Stock Performance Compared to Other Health Providers? - Yahoo Finance
Elevance Health, Inc. $ELV Shares Bought by Northwestern Mutual Wealth Management Co. - MarketBeat
Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability - Yahoo Finance
Elevance Health (ELV): Bridging the Gap between Care and Coverage - finance.yahoo.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Shenzhen Edge Medical Co., Ltd. Class H (HK:2675), Elevance Health (ELV) and 4DMedical Ltd (AU:4DX) - The Globe and Mail
Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 13.86% Potential Upside for Investors - DirectorsTalk Interviews
Court Lets Elevance Pursue Medicare Star Rating Bonus Claim - Bloomberg Law News
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy? - TradingView
Elevance Health, Inc. (ELV) Stock Analysis: Riding a 12.12% Potential Upside with Strong Analyst Support - DirectorsTalk Interviews
Elevance Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
$3.6M Anthem denied benefits class action settlement - Top Class Actions
Is UnitedHealth Finding a Better Path to Medicare Advantage Growth? - TradingView
Elevance Health Gets Final OK On $14.75M Nurse OT Deal - Law360
Elevance Health stock draws fresh institutional buying as consensus targets stay above current level - Ad-hoc-news.de
Can Humana's Star Ratings Rebound Unlock MA Earnings Power? - TradingView
Elevance Health Inc Azioni (ELV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):